6.91
+0.25(+3.75%)
Currency In USD
| Previous Close | 6.66 |
| Open | 6.53 |
| Day High | 7.1 |
| Day Low | 6.53 |
| 52-Week High | 2,928 |
| 52-Week Low | 4.22 |
| Volume | 140,920 |
| Average Volume | 1.37M |
| Market Cap | 3.92M |
| PE | 0 |
| EPS | -2,441.21 |
| Moving Average 50 Days | 6.2 |
| Moving Average 200 Days | 25.32 |
| Change | 0.25 |
If you invested $1000 in GlucoTrack, Inc. (GCTK) 10 years ago, it would be worth $0.02 as of October 21, 2025 at a share price of $6.91. Whereas If you bought $1000 worth of GlucoTrack, Inc. (GCTK) shares 5 years ago, it would be worth $0.21 as of October 21, 2025 at a share price of $6.91.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Glucotrack to Participate in the Q3 Virtual Investor Summit
GlobeNewswire Inc.
Sep 11, 2025 12:00 PM GMT
RUTHERFORD, N.J., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabe
Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology
GlobeNewswire Inc.
Aug 06, 2025 12:30 PM GMT
Experienced cardiac electrophysiologist joins Glucotrack’s growing clinical advisory team as the Company advances its long-term CBGM through critical clinical milestonesRUTHERFORD, N.J., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: G
Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting
GlobeNewswire Inc.
Jul 31, 2025 12:30 PM GMT
Company to present endocrinologist perspectives on implantable CBGM technology as it advances toward US pilot studyRUTHERFORD, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design,